SCHEMBL5748703

SCHEMBL5748703

O=[C]NCCN1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1307630 0.95 CARM1 (0.50)
SCHEMBL348038 0.93 CARM1 (0.48)
SCHEMBL1785086 0.84 HDAC2 (0.41)
SCHEMBL3951607 0.82 SLC2A1 (0.37)
SCHEMBL3949628 0.82 ALDH1A1 (0.43)
SCHEMBL1306925 0.82 HRH3 (0.46)
SCHEMBL3948277 0.82 SLC2A1 (0.38)
SCHEMBL3955882 0.80 HSD17B10 (0.48)
SCHEMBL272484 0.80 KDM4E (0.47)
SCHEMBL1781617 0.80 HRH3 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020446-B1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO LTD (JP) 2006-03-15 EP disclosed
US-6300331-B1 DRUGS AS ANTITUMOR AGENTS OR ANTICARCINOGENIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
EP-1020446-A1 NAPHTHALIMIDOBENZAMIDE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed